Literature DB >> 22619321

A restricted subset of var genes mediates adherence of Plasmodium falciparum-infected erythrocytes to brain endothelial cells.

Marion Avril1, Abhai K Tripathi, Andrew J Brazier, Cheryl Andisi, Joel H Janes, Vijaya L Soma, David J Sullivan, Peter C Bull, Monique F Stins, Joseph D Smith.   

Abstract

Cerebral malaria (CM) is a deadly complication of Plasmodium falciparum infection, but specific interactions involved in cerebral homing of infected erythrocytes (IEs) are poorly understood. In this study, P. falciparum-IEs were characterized for binding to primary human brain microvascular endothelial cells (HBMECs). Before selection, CD36 or ICAM-1-binding parasites exhibited punctate binding to a subpopulation of HBMECs and binding was CD36 dependent. Panning of IEs on HBMECs led to a more dispersed binding phenotype and the selection of three var genes, including two that encode the tandem domain cassette 8 (DC8) and were non-CD36 binders. Multiple domains in the DC8 cassette bound to brain endothelium and the cysteine-rich interdomain region 1 inhibited binding of P. falciparum-IEs by 50%, highlighting a key role for the DC8 cassette in cerebral binding. It is mysterious how deadly binding variants are maintained in the parasite population. Clonal parasite lines expressing the two brain-adherent DC8-var genes did not bind to any of the known microvascular receptors, indicating unique receptors are involved in cerebral binding. They could also adhere to brain, lung, dermis, and heart endothelial cells, suggesting cerebral binding variants may have alternative sequestration sites. Furthermore, young African children with CM or nonsevere control cases had antibodies to HBMEC-selected parasites, indicating they had been exposed to related variants during childhood infections. This analysis shows that specific P. falciparum erythrocyte membrane protein 1 types are linked to cerebral binding and suggests a potential mechanism by which individuals may build up immunity to severe disease, in the absence of CM.

Entities:  

Mesh:

Year:  2012        PMID: 22619321      PMCID: PMC3387091          DOI: 10.1073/pnas.1120534109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  59 in total

1.  Disruption of Plasmodium falciparum erythrocyte rosettes by standard heparin and heparin devoid of anticoagulant activity.

Authors:  J Carlson; H P Ekre; H Helmby; J Gysin; B M Greenwood; M Wahlgren
Journal:  Am J Trop Med Hyg       Date:  1992-05       Impact factor: 2.345

2.  An immunohistochemical study of the pathology of fatal malaria. Evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration.

Authors:  G D Turner; H Morrison; M Jones; T M Davis; S Looareesuwan; I D Buley; K C Gatter; C I Newbold; S Pukritayakamee; B Nagachinta
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

3.  Rolling and stationary cytoadhesion of red blood cells parasitized by Plasmodium falciparum: separate roles for ICAM-1, CD36 and thrombospondin.

Authors:  B M Cooke; A R Berendt; A G Craig; J MacGregor; C I Newbold; G B Nash
Journal:  Br J Haematol       Date:  1994-05       Impact factor: 6.998

4.  Microvascular sequestration of parasitized erythrocytes in human falciparum malaria: a pathological study.

Authors:  E Pongponratn; M Riganti; B Punpoowong; M Aikawa
Journal:  Am J Trop Med Hyg       Date:  1991-02       Impact factor: 2.345

5.  Rapid switching to multiple antigenic and adhesive phenotypes in malaria.

Authors:  D J Roberts; A G Craig; A R Berendt; R Pinches; G Nash; K Marsh; C I Newbold
Journal:  Nature       Date:  1992-06-25       Impact factor: 49.962

6.  Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration.

Authors:  G G MacPherson; M J Warrell; N J White; S Looareesuwan; D A Warrell
Journal:  Am J Pathol       Date:  1985-06       Impact factor: 4.307

Review 7.  The sick placenta-the role of malaria.

Authors:  B J Brabin; C Romagosa; S Abdelgalil; C Menéndez; F H Verhoeff; R McGready; K A Fletcher; S Owens; U D'Alessandro; F Nosten; P R Fischer; J Ordi
Journal:  Placenta       Date:  2004-05       Impact factor: 3.481

8.  Protection against clinical malaria by heterologous immunoglobulin G antibodies against malaria-infected erythrocyte variant surface antigens requires interaction with asymptomatic infections.

Authors:  Samson M Kinyanjui; Tabitha Mwangi; Peter C Bull; Christopher I Newbold; Kevin Marsh
Journal:  J Infect Dis       Date:  2004-09-22       Impact factor: 5.226

9.  Adherence of infected erythrocytes to venular endothelium selects for antigenic variants of Plasmodium falciparum.

Authors:  B A Biggs; R F Anders; H E Dillon; K M Davern; M Martin; C Petersen; G V Brown
Journal:  J Immunol       Date:  1992-09-15       Impact factor: 5.422

10.  Plasmodium falciparum associated with severe childhood malaria preferentially expresses PfEMP1 encoded by group A var genes.

Authors:  Anja T R Jensen; Pamela Magistrado; Sarah Sharp; Louise Joergensen; Thomas Lavstsen; Antonella Chiucchiuini; Ali Salanti; Lasse S Vestergaard; John P Lusingu; Rob Hermsen; Robert Sauerwein; Jesper Christensen; Morten A Nielsen; Lars Hviid; Colin Sutherland; Trine Staalsoe; Thor G Theander
Journal:  J Exp Med       Date:  2004-05-03       Impact factor: 14.307

View more
  106 in total

1.  Molecular basis of severe malaria.

Authors:  Kirk W Deitsch; Chetan E Chitnis
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-07       Impact factor: 11.205

Review 2.  Malaria immunity in man and mosquito: insights into unsolved mysteries of a deadly infectious disease.

Authors:  Peter D Crompton; Jacqueline Moebius; Silvia Portugal; Michael Waisberg; Geoffrey Hart; Lindsey S Garver; Louis H Miller; Carolina Barillas-Mury; Susan K Pierce
Journal:  Annu Rev Immunol       Date:  2014       Impact factor: 28.527

Review 3.  The role of PfEMP1 adhesion domain classification in Plasmodium falciparum pathogenesis research.

Authors:  Joseph D Smith
Journal:  Mol Biochem Parasitol       Date:  2014-07-23       Impact factor: 1.759

4.  Cross-reactive immune responses as primary drivers of malaria chronicity.

Authors:  Eili Y Klein; Andrea L Graham; Manuel Llinás; Simon Levin
Journal:  Infect Immun       Date:  2013-10-14       Impact factor: 3.441

5.  Infectious disease: Pathogenesis of cerebral malaria-a step forward.

Authors:  Sudhanshu S Pati; Saroj K Mishra
Journal:  Nat Rev Neurol       Date:  2012-07-24       Impact factor: 42.937

6.  Clonal variants of Plasmodium falciparum exhibit a narrow range of rolling velocities to host receptor CD36 under dynamic flow conditions.

Authors:  Thurston Herricks; Marion Avril; Joel Janes; Joseph D Smith; Pradipsinh K Rathod
Journal:  Eukaryot Cell       Date:  2013-09-06

Review 7.  Of men in mice: the success and promise of humanized mouse models for human malaria parasite infections.

Authors:  Alexis Kaushansky; Sebastian A Mikolajczak; Marissa Vignali; Stefan H I Kappe
Journal:  Cell Microbiol       Date:  2014-03-06       Impact factor: 3.715

Review 8.  Malaria biology and disease pathogenesis: insights for new treatments.

Authors:  Louis H Miller; Hans C Ackerman; Xin-zhuan Su; Thomas E Wellems
Journal:  Nat Med       Date:  2013-02-06       Impact factor: 53.440

9.  Spatial and temporal mapping of the PfEMP1 export pathway in Plasmodium falciparum.

Authors:  Paul J McMillan; Coralie Millet; Steven Batinovic; Mauro Maiorca; Eric Hanssen; Shannon Kenny; Rebecca A Muhle; Martin Melcher; David A Fidock; Joseph D Smith; Matthew W A Dixon; Leann Tilley
Journal:  Cell Microbiol       Date:  2013-03-14       Impact factor: 3.715

10.  A novel domain cassette identifies Plasmodium falciparum PfEMP1 proteins binding ICAM-1 and is a target of cross-reactive, adhesion-inhibitory antibodies.

Authors:  Anja Bengtsson; Louise Joergensen; Thomas S Rask; Rebecca W Olsen; Marianne A Andersen; Louise Turner; Thor G Theander; Lars Hviid; Matthew K Higgins; Alister Craig; Alan Brown; Anja T R Jensen
Journal:  J Immunol       Date:  2012-12-03       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.